Evidence map›Paper›PMID 25012376›Full record

ReviewAdvances in experimental medicine and biology2014

Does brain inflammation mediate pathological outcomes in epilepsy?

Karen S Wilcox, Annamaria Vezzani

Open access · greenAbstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
41.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. COX-2/PGEEpilepsia open · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Karen S WilcoxDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, 84108, USA, Karen.wilcox@hsc.utah.edu.
Annamaria Vezzani
Mario Negri Institute for Pharmacological Research · ITUniversity of Utah · US

Funding

Role of microglia in a novel model of temporal lobe epilepsyR37NS065434 · NINDS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI WILCOX, KAREN S · 2019 to 2025
$2.6M
Calcium Signaling in a Model of Temporal Lobe EpilepsyR01NS078331 · NINDS · UNIVERSITY OF UTAH · PI WHITE, JOHN A., WILCOX, KAREN S · 2012 to 2016
$2.0M
A Novel Mouse Model of Temporal Lobe EpilepsyR01NS065434 · NINDS · UNIVERSITY OF UTAH · PI WHITE, H STEVE, WILCOX, KAREN S · 2011 to 2013
$887k
NINDS NIH HHS NS065434NINDS NIH HHS NS078331NINDS NIH HHS R01 NS065434NINDS NIH HHS R01 NS078331NINDS NIH HHS R37 NS065434
6 · The paper itself

Abstract

Inflammation in the central nervous system (CNS) is associated with epilepsy and is characterized by the increased levels of a complex set of soluble molecules and their receptors in epileptogenic foci with profound neuromodulatory effects. These molecules activate receptor-mediated pathways in glia and neurons that contribute to hyperexcitability in neural networks that underlie seizure generation. As a consequence, exciting new opportunities now exist for novel therapies targeting the various components of the immune system and the associated inflammatory mediators, especially the IL-1β system. This review summarizes recent findings that increased our understanding of the role of inflammation in reducing seizure threshold, contributing to seizure generation, and participating in epileptogenesis. We will discuss preclinical studies supporting the hypothesis that pharmacological inhibition of specific proinflammatory signalings may be useful to treat drug-resistant seizures in human epilepsy, and possibly delay or arrest epileptogenesis.

Indexed as

EncephalitisEpilepsyHumansInflammation MediatorsNeuronal PlasticitySynaptic TransmissionInflammation Mediators

Identifiers

PMID25012376
PMCPMC4867105
OpenAlexW1644127769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.